{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:41:15Z","timestamp":1771594875805,"version":"3.50.1"},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This review provides an updated and comprehensive overview of the diagnosis and management of splanchnic venous thrombosis (SVT), a rare but clinically important manifestation of venous thrombosis involving the portal, mesenteric, splenic, and hepatic veins. The aim of this article is to summarize and critically appraise recent advances in the evidence base for anticoagulant therapy, prognosis, and clinical decision-making across the diverse clinical settings in which SVT occurs, including the most important subgroups of liver disease, myeloproliferative neoplasms, and solid malignancy. The review integrates findings from prospective studies, meta-analyses, and registry data and highlights the evolving role of direct oral anticoagulants (DOACs) as an alternative to vitamin K antagonists and low-molecular-weight heparins. Meta-analyses demonstrate that anticoagulation increases the likelihood of vessel recanalization and improves survival in cirrhotic portal vein thrombosis (PVT) without increasing major bleeding. Pooled data suggest that DOACs achieve at least comparable efficacy to conventional anticoagulant drugs, with lower rates of thrombus growth and major bleeding, while low-dose rivaroxaban has proven effective for secondary prevention in chronic non-cirrhotic PVT. In cancer-associated SVT, anticoagulation reduces recurrence with acceptable bleeding risk, and in Budd\u2013Chiari syndrome, DOACs show promising safety and efficacy in selected patients. Despite major progress in recent years, most evidence still remains observational, and randomized trials, pediatric data, and studies on long-term secondary prevention are urgently needed to further refine and standardize SVT management.<\/jats:p>","DOI":"10.1055\/a-2749-6835","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:30:27Z","timestamp":1771371027000},"page":"071-077","source":"Crossref","is-referenced-by-count":1,"title":["Management of Splanchnic Venous Thrombosis: An Update"],"prefix":"10.1055","volume":"46","author":[{"given":"Heiko","family":"R\u00fchl","sequence":"additional","affiliation":[{"name":"Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Reda","sequence":"additional","affiliation":[{"name":"Institute of Transfusion Medicine, University Hospital Cologne, Cologne, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtha.2024.10.012","article-title":"Splanchnic vein thrombosis: management for the thrombosis specialist","volume":"23","author":"K J Barnum","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"W Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari syndrome","volume":"117","author":"W Ageno","year":"2017","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis","volume":"104","author":"J Pan","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ajh.26896","article-title":"Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies","volume":"98","author":"J J Kiladjian","year":"2023","journal-title":"Am J Hematol"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: A systematic review and meta-analysis","volume":"137","author":"E Valeriani","year":"2021","journal-title":"Blood"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: An individual patient data meta-analysis","volume":"6","author":"M Candeloro","year":"2022","journal-title":"Blood Adv"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/a-2178-6670","article-title":"Diagnosis and therapy of visceral vein thrombosis: An update based on the Revised AWMF S2k Guideline","volume":"44","author":"K S M\u00fchlberg","year":"2024","journal-title":"Hamostaseologie"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1055\/s-0040-1716716","article-title":"Magnetic resonance thrombus imaging to differentiate acute from chronic portal vein thrombosis","volume":"4","author":"L F van Dam","year":"2020","journal-title":"TH Open"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"II Faculty. Baveno VII: Renewing consensus in portal hypertension","volume":"76","author":"R de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"M G Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: An interventional prospective cohort study","volume":"6","author":"W Ageno","year":"2022","journal-title":"Blood Adv"},{"key":"ref13","first-page":"10","article-title":"Effect of direct oral anticoagulants in patients with splanchnic vein thrombosis: A systematic reviews and meta-analysis","volume":"30","author":"Y Wan","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jtha.2023.10.023","article-title":"Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: A pooled analysis of literature studies","volume":"22","author":"I Calcaterra","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report","volume":"160","author":"S M Stevens","year":"2021","journal-title":"Chest"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"M Di Nisio","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: A multicentre, international prospective registry","volume":"3","author":"N Riva","year":"2016","journal-title":"Lancet Haematol"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jtha.2023.03.002","article-title":"Clinical course and treatment of incidentally detected splanchnic vein thrombosis: An individual patient data meta-analysis","volume":"21","author":"M Candeloro","year":"2023","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"A Tufano","year":"2018","journal-title":"Thromb Res"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.jtha.2024.06.029","article-title":"Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: A systematic review and meta-analysis","volume":"22","author":"P Chrysafi","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: Molecular-driven diagnosis and long-term treatment","volume":"115","author":"V De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/ijms26010292","article-title":"Assessment of hypercoagulability in splanchnic vein thrombosis by measurement of the hemostasis enzymes thrombin and activated protein C","volume":"26","author":"S Reda","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"14","key":"ref23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMra2207738","article-title":"Primary Budd-Chiari syndrome","volume":"388","author":"J C Garcia-Pag\u00e1n","year":"2023","journal-title":"N Engl J Med"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00270-014-0919-9","article-title":"Diagnosis and management of Budd Chiari syndrome: An update","volume":"38","author":"A Copelan","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cgh.2022.04.024","article-title":"Outcome of Budd-Chiari syndrome patients treated with direct oral anticoagulants: An Austrian multicenter study","volume":"21","author":"G Semmler","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/hematology.2023000481","article-title":"How to manage splanchnic vein thrombosis in patients with liver disease","volume":"2023","author":"N Riva","year":"2023","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"07","key":"ref27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: A systematic review and meta-analysis","volume":"121","author":"E Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis","volume":"79","author":"A Guerrero","year":"2023","journal-title":"J Hepatol"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"e70114","DOI":"10.1111\/liv.70114","article-title":"Safety of anticoagulant treatment in patients with splanchnic vein thrombosis and history of portal hypertension-related bleeding","volume":"45","author":"R Talerico","year":"2025","journal-title":"Liver Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2023.12.014","article-title":"Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations","volume":"234","author":"O Cohen","year":"2024","journal-title":"Thromb Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2019.11.023","article-title":"Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer","volume":"185","author":"A Afzal","year":"2020","journal-title":"Thromb Res"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2015-03-631119","article-title":"Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival","volume":"126","author":"K K S\u00f8gaard","year":"2015","journal-title":"Blood"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jth.15214","article-title":"Clinical history of cancer-associated splanchnic vein thrombosis","volume":"19","author":"E Valeriani","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000513368","article-title":"Trends and in-hospital outcomes of splanchnic vein thrombosis associated with gastrointestinal malignancies: A nationwide analysis","volume":"8","author":"S Handa","year":"2021","journal-title":"Gastrointest Tumors"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2023.10.002","article-title":"Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes","volume":"231","author":"A Garc\u00eda-Villa","year":"2023","journal-title":"Thromb Res"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"A Falanga","year":"2023","journal-title":"Ann Oncol"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.dld.2023.04.026","article-title":"Determinants and impact of splanchnic vein thrombosis in acute pancreatitis","volume":"55","author":"D Oy\u00f3n","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jgh.15711","article-title":"Incidence and treatment of splanchnic vein thrombosis in patients with acute pancreatitis: A systematic review and meta-analysis","volume":"37","author":"F S Anis","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"ref39","first-page":"10","article-title":"Anticoagulation therapy for splanchnic vein thrombosis associated with acute pancreatitis: A systematic review and meta-analysis","volume":"29","author":"Y Yin","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: Disorders of the hepatic and mesenteric circulation","volume":"115","author":"D A Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"a2200104","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"A Plessier","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"M-H Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MBC.0000000000000901","article-title":"The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis","volume":"31","author":"D Tremblay","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"09","key":"ref44","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.jtha.2023.05.014","article-title":"Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"21","author":"O Cohen","year":"2023","journal-title":"J Thromb Haemost"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2749-6835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:31:43Z","timestamp":1771371103000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2749-6835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["a27496835"],"URL":"https:\/\/doi.org\/10.1055\/a-2749-6835","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}